Immunic AG | Finanzwire

Basculer en Français

9804	Companies
196632	Keywords
127649	Articles
104544	Press releases

Home
Companies
Immunic AG

BRIEF

published on 04/10/2025 at 19:05, 9 months 24 days ago

Immunic Closes $5.1 Million Direct Offering Led by Aberdeen Investments

Biotechnology Chronic Diseases Direct Offering Aberdeen Investments Immunic Funding
PRESS RELEASE

published on 04/10/2025 at 19:00, 9 months 24 days ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. closes $5.1 million direct offering led by Aberdeen Investments to fund clinical trials and operations for autoimmune diseases. Issued via PRNewswire

Clinical Trials Immunic Inc. Autoimmune Diseases Direct Offering Aberdeen Investments
BRIEF

published on 04/09/2025 at 14:15, 9 months 25 days ago

Immunic, Inc. Announces $5.1 Million Direct Offering Guided by Aberdeen Investments

Biotechnology Nasdaq Investment Immunic, Inc. Direct Offering
PRESS RELEASE

published on 04/09/2025 at 14:10, 9 months 25 days ago

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations

Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments
BRIEF

published on 04/01/2025 at 12:35, 10 months 3 days ago

Immunic, Inc. Announces Participation in Key April Conferences

Biotechnology Conférences Immunic Inc. Vidofludimus Calcium Neuroprotection
PRESS RELEASE

published on 04/01/2025 at 12:30, 10 months 3 days ago

Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. to participate in scientific and industry conferences in April, including American Academy of Neurology 2025 Annual Meeting and German Biotech Days 2025

Immunic Inc. Industry Conferences Scientific Conferences American Academy Of Neurology German Biotech Days
BRIEF

published on 03/03/2025 at 12:35, 11 months 1 day ago

Immunic to Join March Conferences to Present Research

Biotechnology Investor Relations Conférences Antiviral Research Virology
PRESS RELEASE

published on 03/03/2025 at 12:30, 11 months 1 day ago

Immunic to Participate in Scientific and Investor Conferences in March
Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami

Biotechnology Investor Conferences Clinical Pipeline Immunic Scientific Conferences
BRIEF

published on 02/26/2025 at 12:35, 11 months 6 days ago

Immunic Shares Promising Data on Vidofludimus Calcium at ACTRIMS Forum 2025

Multiple Sclerosis Vidofludimus Calcium Neuroprotection Nurr1 Activation CALLIPER Trial
PRESS RELEASE

published on 02/26/2025 at 12:30, 11 months 6 days ago

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April

Clinical Trial Multiple Sclerosis Immunic Vidofludimus Calcium ACTRIMS Forum 2025

Accesswire

Published on 02/04/2026 at 18:00, 3 hours 2 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 4 hours 47 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 5 hours 17 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 6 hours 2 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 6 hours 32 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 8 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 26 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 1 hour 1 minute ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 2 hours 7 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 2 hours 21 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 2 hours 58 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 3 hours 17 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 3 hours 17 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 3 hours 17 minutes ago

January 2026
Published on 02/04/2026 at 17:45, 3 hours 17 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE